Secondary diarrheal disease outcomes were measures of the severity of diarrhea (duration of episodes, maximum number of stools during an episode, episodes lasting 14 or more days, diarrhea episodes with blood in the stool, and clinic visits for diarrhea) and the distribution of diarrheal morbidity (proportion of children who ever had diarrhea and number of episodes per child).
The secondary end points included the primary MPE control rate, time to drainage tube removal, EFFS, treatment-related morbidity, proportion of late pericardial or cardiac complication, overall survival (OS) and symptom scores.
Secondary outcome variables were lactates at the end of surgery, postoperative complications at day 30, postoperative morbidity (the proportion of patients who developed one or more complications) at day 30, mortality at day 30, hospital length of stay, and costs.
Exacerbating these challenges are the growing numbers of individuals with chronic disease and multi- morbidities, a proportion of who develop complex health conditions.
Findings on cerebral ultrasonography—Unlike the other major morbidities, the proportion of surviving babies who had a severe abnormality reported on cerebral ultrasonography (13%, 95% confidence interval 11%to15%5%) was not related to gestational age (table 2).
Finally, we fitted a Poisson regression model predicting weekly excess P&I mortality in persons aged 65 years or more from the weekly excess ILI morbidity, the weekly proportion of cases aged 65 years or more out of all ILI, and the dominant influenza virus types or subtypes (A/H3N2, A/H1N1, B).
Meanwhile, additional studies are needed due to the undiagnosed aspect of severe morbidity in substantial proportion.
In the extension of morbidity scenarios the proportion of remaining life spent in each state is equal to the baseline scenario.
Conclusion Survival of babies born between 22 and 25 weeks' gestation has increased since 1995 but the pattern of major neonatal morbidity and the proportion of survivors affected are unchanged.
In addition it requires significant theatre time, and can be a cause of morbidity in a proportion of patients, so there is still discussion in the literature of its value and cost effectiveness[ 6].
Several factors, such as a lower incidence of co-morbidity, the low proportion of patients with septic shock and the high proportion of adequate empirical treatment among our patients with Enterobacteriaceae bacteraemia may contribute to the low mortality [ 12].
